The effect of the Spending review makes generics soar

"Spend Less Money on Sales & Marketing"
In a video interview with the Wall Street Journal, Joseph Jimenez, CEO of Novartis, ha dichiarato: "L’industria ha bisogno di spendere di più in R&D it's less on sales and marketing. In the lasts two decades, gran parte della creazione di valore è venuto dalle vendite e dai muscoli del marketing for new drugs. And now There are probably less investments da parte di alcune società For ensure that there will be a continuous stream of innovation.
I modified
l’immagine del famoso "Welsh Wankers" per illustrare l’analogia of the "muscolo" suggested by Jimenez. Il "braccio St & M" del "Pharma Wankers" rappresenta le excessive expenses for sales and marketing, while the  "braccio R & D " rappresenta il underutilization of research and development.
"
Wanker," è un termine pejorative of British origin. Initially named "uno masturbating",  ma da allora è diventato a insult general And commonly it means waste time or, in this case, lose money.
Second
the data Of Cegedim Strategic, Novartis è in the top 10 (Perhaps  quarta  o fifth) for direct-to-consumer spending (DTC) Not a shabby one "Pharma Wankers" per quanto riguarda le sales and marketing of the muscle That it goes. The graph The following shows the top 10 companies that spend directly on the consumer among July 2011 e

Exit mobile version